ESC 365 - Targeted therapy of underlying conditions in patients with persistent atrial fibrillation and mild to moderate stable heart failure: long term outcome of the RACE 3 Trial

EHRA Premium Access

Targeted therapy of underlying conditions in patients with persistent atrial fibrillation and mild to moderate stable heart failure: long term outcome of the RACE 3 Trial

Session: Late Breaking Clinical Trials

Topic: Treatment

Speaker: Professor M. Rienstra (Groningen, NL)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Professor Michiel Rienstra

University Medical Centre Groningen, Groningen (Netherlands (The))

17 presentations

5 followers

3 more presentations in this session

Benefits of systematic screening for Atrial Fibrillation - the STROKESTOP-study

Speaker: Doctor E. Svennberg (Stockholm, SE)

Long term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator registry

Speaker: Professor P. Lambiase (London, GB)

Early treatment of atrial fibrillation for stroke prevention trial

Speaker: Doctor A. Metzner (Hamburg, DE)

Access the full session

Late Breaking Clinical Trials

Speakers: Professor M. Rienstra, Doctor E. Svennberg, Professor P. Lambiase, Doctor A. Metzner

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources